Kyrgyzstan vs Togo: The number of people with susceptibility test result for rifampicin
Kyrgyzstan
1,932
in 2021
Togo
1,805
in 2021
Kyrgyzstan rank
49th
Togo rank
52nd
The number of people with susceptibility test result for rifampicin over time
- Kyrgyzstan
- Togo
How they compare
Kyrgyzstan currently reports 1,932 against 1,805 in Togo, a difference of 127.
That makes Kyrgyzstan's figure about 1.1 times Togo's.
Across all 5 years both countries report, Kyrgyzstan has been ahead every year.
Kyrgyzstan ranks 49th and Togo ranks 52nd of 155 countries.
Kyrgyzstan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,316 | 732 | 1,584 | Kyrgyzstan |
| 2020s | 1,836 | 1,709 | 127.5 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kyrgyzstan or Togo?
- Kyrgyzstan, at 1,932 against 1,805 in Togo as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kyrgyzstan and Togo?
- 127, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Togo?
- 5 years are reported by both, from 2017 to 2021.
- How do Kyrgyzstan and Togo rank globally for the number of people with susceptibility test result for rifampicin?
- Kyrgyzstan ranks 49th and Togo ranks 52nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.